1. Home
  2. CPAC vs IOVA Comparison

CPAC vs IOVA Comparison

Compare CPAC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$10.63

Market Cap

905.9M

Sector

Industrials

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.33

Market Cap

881.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPAC
IOVA
Founded
1949
2007
Country
Peru
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
905.9M
881.3M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
CPAC
IOVA
Price
$10.63
$2.33
Analyst Decision
Sell
Buy
Analyst Count
2
12
Target Price
$10.15
$10.45
AVG Volume (30 Days)
34.5K
12.5M
Earning Date
02-13-2026
02-26-2026
Dividend Yield
5.46%
N/A
EPS Growth
20.27
N/A
EPS
0.15
N/A
Revenue
$601,081,883.00
$250,425,000.00
Revenue This Year
$9.96
$60.71
Revenue Next Year
$1.70
$59.52
P/E Ratio
$14.09
N/A
Revenue Growth
6.18
175.62
52 Week Low
$5.10
$1.64
52 Week High
$11.30
$6.50

Technical Indicators

Market Signals
Indicator
CPAC
IOVA
Relative Strength Index (RSI) 62.78 45.76
Support Level $10.14 $2.21
Resistance Level $10.80 $2.80
Average True Range (ATR) 0.34 0.18
MACD -0.10 -0.05
Stochastic Oscillator 43.16 20.74

Price Performance

Historical Comparison
CPAC
IOVA

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: